Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: A High-Throughput Screen Identifies DYRK1A Inhibitor ID-8 that Stimulates Human Kidney Tubular Epithelial Cell Proliferation.

Authors: Monteiro, Maria B; Ramm, Susanne; Chandrasekaran, Vidya; Boswell, Sarah A; Weber, Elijah J; Lidberg, Kevin A; Kelly, Edward J; Vaidya, Vishal S

Published In J Am Soc Nephrol, (2018 12)

Abstract: The death of epithelial cells in the proximal tubules is thought to be the primary cause of AKI, but epithelial cells that survive kidney injury have a remarkable ability to proliferate. Because proximal tubular epithelial cells play a predominant role in kidney regeneration after damage, a potential approach to treat AKI is to discover regenerative therapeutics capable of stimulating proliferation of these cells.We conducted a high-throughput phenotypic screen using 1902 biologically active compounds to identify new molecules that promote proliferation of primary human proximal tubular epithelial cells in vitro.The primary screen identified 129 compounds that stimulated tubular epithelial cell proliferation. A secondary screen against these compounds over a range of four doses confirmed that eight resulted in a significant increase in cell number and incorporation of the modified thymidine analog EdU (indicating actively proliferating cells), compared with control conditions. These eight compounds also stimulated tubular cell proliferation in vitro after damage induced by hypoxia, cadmium chloride, cyclosporin A, or polymyxin B. ID-8, an inhibitor of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), was the top candidate identified as having a robust proproliferative effect in two-dimensional culture models as well as a microphysiologic, three-dimensional cell culture system. Target engagement and genetic knockdown studies and RNA sequencing confirmed binding of ID-8 to DYRK1A and upregulation of cyclins and other cell cycle regulators, leading to epithelial cell proliferation.We have identified a potential first-in-class compound that stimulates human kidney tubular epithelial cell proliferation after acute damage in vitro.

PubMed ID: 30361326 Exiting the NIEHS site

MeSH Terms: Acute Kidney Injury/drug therapy; Cell Culture Techniques/methods; Cell Cycle/drug effects; Cell Cycle/genetics; Cell Proliferation/drug effects; Cell Proliferation/genetics; Cells, Cultured; Drug Discovery; Drug Evaluation, Preclinical; Epithelial Cells/cytology; Epithelial Cells/drug effects; Epithelial Cells/enzymology; High-Throughput Screening Assays; Humans; Kidney Tubules/cytology; Kidney Tubules/drug effects*; Kidney Tubules/enzymology; Protein Kinase Inhibitors/pharmacology*; Protein-Serine-Threonine Kinases/antagonists & inhibitors*; Protein-Serine-Threonine Kinases/metabolism; Protein-Tyrosine Kinases/antagonists & inhibitors*; Protein-Tyrosine Kinases/metabolism; Regenerative Medicine

to Top